| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/25/2001 | EP0674525B1 Aqueous pharmaceutical preparations of g-csf with a long shelf life |
| 07/25/2001 | EP0585252B1 Pharmaceutical formulations |
| 07/25/2001 | CN1305488A Testosterone derivative |
| 07/25/2001 | CN1305462A Novel 1,5 and 3-O-substituted 1H-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, and method for the production and use thereof as medica |
| 07/25/2001 | CN1305457A Novel antiestrogens, method for production thereof and their pharmaceutical application |
| 07/25/2001 | CN1305381A Cyclophosphamide coated tablets |
| 07/25/2001 | CN1305380A Use of composition comprising Formoterol and Budesonide for prevention or treatment of acute condition of asthma |
| 07/25/2001 | CN1305379A Method of treatment |
| 07/25/2001 | CN1305374A Oxazolidinones to treat eye infections |
| 07/25/2001 | CN1305372A Method of manufacturing adhesive plaster |
| 07/25/2001 | CN1305371A Multiparticulate pharmaceutical form with programmed and timed release and preparation method |
| 07/25/2001 | CN1305369A Pharmaceutical aerosol formulation |
| 07/25/2001 | CN1305368A Implants for administering substances and methods of producing implants |
| 07/25/2001 | CN1304773A Amphoteric diluent and disintegrating agent composition, its preparation method and use |
| 07/25/2001 | CN1304767A Plaster for treating infantile parotitis and its preparing process |
| 07/25/2001 | CN1304759A Dermatitis ointment and its preparing process |
| 07/25/2001 | CN1304753A Ganlu pill and its preparing process |
| 07/25/2001 | CN1304751A Scrophularia capsule and its preparing process |
| 07/25/2001 | CN1304742A Ointment for treating bone fracture and injury |
| 07/25/2001 | CN1304741A Lumbago plaster |
| 07/25/2001 | CN1304740A Hyperosteogeny plaster |
| 07/25/2001 | CN1304739A Plaster for treating periomethritis |
| 07/25/2001 | CN1304738A Quick-acting plaster for treating rheumatic arthritis |
| 07/25/2001 | CN1304728A Soft yolk oil capsule |
| 07/25/2001 | CN1304723A Tanshinone compounds containing dihydrofuran ring structure used for medicine to treat hepatic encephalopathy |
| 07/25/2001 | CN1068789C Tuberculosis treating medicine and its compounding process |
| 07/25/2001 | CN1068788C Anticancer and pain-releving paster |
| 07/25/2001 | CN1068787C Health paster for treating prostatosis and preparing process thereof |
| 07/25/2001 | CN1068785C Chinese patent medicine for external application for curing diseases of scald, burn and dermal ulcer |
| 07/25/2001 | CN1068784C External used medicinal liquor for preventing and curing multiple diseases |
| 07/25/2001 | CN1068781C Chinese medicine of spraying-applying dual puropose mailnly for treating burn and scald preparation method thereof |
| 07/25/2001 | CN1068780C 'Anluohuaxianwan' pill and producing process thereof |
| 07/25/2001 | CN1068779C 'Shutonghuaxianwan' pill anud producing process thereof |
| 07/25/2001 | CN1068778C Drag composition for treating and curing and its preparing method |
| 07/24/2001 | US6265449 Aqueous compositions comprising ranitidine and LCMT sucrose |
| 07/24/2001 | US6265448 administering toremifene |
| 07/24/2001 | US6265444 Ophthalmic composition |
| 07/24/2001 | US6265435 Topical applying loop diuretic in aqueous solution |
| 07/24/2001 | US6265392 Solubilizing agent and an antioxidant, wherein the solution has less than or equal to about 1 ppm of aluminum during the shelf life of the composition. |
| 07/24/2001 | US6265389 Microencapsulation and sustained release of oligonucleotides |
| 07/24/2001 | US6265377 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 07/24/2001 | US6265218 Introducing promoter and heterologous dna encoding a product into plasmid containing antibiotic resistance selection marker, amplifying, using restriction enzymes to form two fragments, cyclizing to form separate plasmids |
| 07/24/2001 | US6264991 Administering drug in polymer microsphere |
| 07/24/2001 | US6264990 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity. |
| 07/24/2001 | US6264989 Spherical single-substance particles, medicines and foodstuffs containing the particles, and method of production thereof |
| 07/24/2001 | US6264988 Reduce bleeding time in animal |
| 07/24/2001 | US6264987 Method for preparing microparticles having a selected polymer molecular weight |
| 07/24/2001 | US6264986 Emulsification, mixing, drying |
| 07/24/2001 | US6264985 Laminated tablet with pointed core |
| 07/24/2001 | US6264984 Effervescent histamine H2 antagonist composition |
| 07/24/2001 | US6264983 Directly compressible, ultra fine acetaminophen compositions and process for producing same |
| 07/24/2001 | US6264982 Plant extracts |
| 07/24/2001 | US6264981 Oral transmucosal drug dosage using solid solution |
| 07/24/2001 | US6264980 Transdermal resorption of active substances from supercooled masses of levulic acid |
| 07/24/2001 | US6264979 Transdermal device for administration through de-epithelialized skin |
| 07/24/2001 | US6264978 Transdermal application system containing acetylsalicylic acid for antithrombotic therapy and cancer prophylaxis |
| 07/24/2001 | US6264977 Transdermal therapeutic system, its use and production process |
| 07/24/2001 | US6264975 Methods of hydrating mucosal surfaces |
| 07/24/2001 | US6264974 Buccal and sublingual administration of physostigmine |
| 07/24/2001 | US6264973 Apparatus and method for anesthetizing the cervical region of a female |
| 07/24/2001 | US6264971 Ocular insert |
| 07/24/2001 | US6264970 Biodegradable polymer |
| 07/24/2001 | US6264965 Composition in the form of an O/W emulsion with a high wax content and uses thereof in cosmetics and dermatology |
| 07/24/2001 | US6264961 Oil-water emulsifiers |
| 07/24/2001 | US6264943 Parkinson's disease |
| 07/24/2001 | US6264941 Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| 07/24/2001 | US6264935 Hypotensive agent for eyes |
| 07/24/2001 | US6264927 Mixture of diethyl ether and iodine |
| 07/24/2001 | US6264925 Prevention, removal dental plaque |
| 07/24/2001 | US6264924 Oral care compositions comprising chlorite and methods |
| 07/24/2001 | US6264923 Antiinflammatory steroid |
| 07/24/2001 | US6264922 Liquid drops containing mixture of liquid, crystal therapeutic agent and surfactant |
| 07/24/2001 | US6264680 Apparatuses and processes for whole-body hyperthermia |
| 07/24/2001 | US6264638 Intravaginal drug delivery system and discharge collection device |
| 07/24/2001 | US6263880 Method of enhancing blood flow in tissue |
| 07/24/2001 | CA2331719A1 Rapidly disintegrating and fast-dissolving solid dosage form |
| 07/24/2001 | CA2285266C Extended release formulations of erythromycin derivatives |
| 07/24/2001 | CA2229184C Supersaturated transdermal drug delivery systems, and methods for manufacturing the same |
| 07/24/2001 | CA2220703C Pharmaceutical compositions for the treatment of alcohol addiction |
| 07/24/2001 | CA2193454C Bioadhesive pharmaceutical composition for the controlled release of active ingredients |
| 07/24/2001 | CA2049822C Stable aqueous preparation |
| 07/24/2001 | CA2030773C Stabilized solutions of psychotropic agents |
| 07/21/2001 | CA2332469A1 Nanoemulsions containing amphiphilic lipids and a non-ionic polymer and its use |
| 07/21/2001 | CA2332468A1 Nanoemulsions containing amphiphilic lipids and an peg ester and its use |
| 07/19/2001 | WO2001051617A1 Monocyte-derived dendritic cell subsets |
| 07/19/2001 | WO2001051512A2 Human and parasite orphan receptor proteins |
| 07/19/2001 | WO2001051463A1 Glyburide composition |
| 07/19/2001 | WO2001051454A1 Compounds and compositions for delivering active agents |
| 07/19/2001 | WO2001051196A1 Templating of solid particles by polymer multilayers |
| 07/19/2001 | WO2001051108A1 Implantable, refillable infusion device and septum replacement kit |
| 07/19/2001 | WO2001051090A2 Amphilic and ionic polymer matrixes and derivatives thereof |
| 07/19/2001 | WO2001051089A1 Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary |
| 07/19/2001 | WO2001051088A1 Composition for reducing plasma triglycerides, platelet aggregation, and oxidative capacity |
| 07/19/2001 | WO2001051087A2 Novel treatment for eye disease |
| 07/19/2001 | WO2001051082A1 Composition of antigen and glycolipid adjuvant sublingual administration |
| 07/19/2001 | WO2001051071A2 Transepithelial delivery of glp-1 derivatives |
| 07/19/2001 | WO2001051070A1 Physiologically active substance eem-s originating in mushrooms, process for producing the same and drugs |
| 07/19/2001 | WO2001051069A1 Use of dictyotal extracts in the production of a topical composition |
| 07/19/2001 | WO2001051066A2 Reduction in bacterial colonization by administering bacteriophage compositions |
| 07/19/2001 | WO2001051065A1 Perfusion liquid preparations for ophthalmic operations |